| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |